Cardiogenics Holding – Securities Purchase Agreement (June 13th, 2014)

This SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of _____________, 2014, is between Cardiogenics Holdings Inc., a Nevada corporation, (the "Company"), and the investor (the "Investor"), as set forth in the signature page to this Agreement.

Cardiogenics Holding – Convertible Debenture Unit Purchase Agreement (June 3rd, 2013)

CONVERTIBLE DEBENTURE UNIT PURCHASE AGREEMENT, dated as of ___________________, 2013 (this "Agreement"), is entered into by and between CARDIOGENICS HOLDINGS INC., a Nevada corporation (the "Company"), and each individual or entity named on an executed signature page hereto (each such signatory is referred to as a "Purchaser") (each agreement with a Purchaser being deemed a separate and independent agreement between the Company and such Purchaser).

Cardiogenics Holding – Cardiogenics Holdings Inc. (June 3rd, 2013)

This will confirm, as required by SS 1 (b) of the Debenture, that CardioGenics Holdings Inc. ("CardioGenics") will establish an escrow account with TD Bank Canada (or such other comparable bank as CardioGenics may determine) through which CardioGenics shall make the required monthly interest payments to you pursuant to the terms of the Debenture (the "Interest Escrow Account").

Cardiogenics Holding – Convertible Debenture Unit Purchase Agreement (March 4th, 2013)

CONVERTIBLE DEBENTURE UNIT PURCHASE AGREEMENT, dated as of _____________, 201__ (this "Agreement"), is entered into by and between CARDIOGENICS HOLDINGS INC., a Nevada corporation (the "Company"), and each individual or entity named on an executed signature page hereto (each such signatory is referred to as a "Purchaser") (each agreement with a Purchaser being deemed a separate and independent agreement between the Company and such Purchaser).

Cardiogenics Holding – Intellectual Property Assignment & License Agreement (June 22nd, 2011)

THIS INTELLECTUAL PROPERTY ASSIGNMENT & LICENSE AGREEMENT (this "Agreement") is made and dated as of June 21, 2011 (the "Effective Date") by and between CARDIOGENICS INC., an Ontario corporation with its principal office and place of business at 6295 Northam Drive, Unit 8, Mississauga, Ontario L4V 1W8 Canada ("CardioGenics") and LUXSPHERES INC., an Ontario corporation with its principal office and place of business at 6295 Northam Drive, Unit 8, Mississauga, Ontario L4V 1W8 Canada ("Luxspheres").

Cardiogenics Holding – Redemption Notice (March 2nd, 2011)

This will serve as notice that CardioGenics Holdings Inc. (the "Company") hereby redeems all issued and outstanding Series 3 Class B Shares of the Company as follows:

Cardiogenics Holding – Redemption Notice (March 2nd, 2011)

This will serve as notice that CardioGenics Holdings Inc. (the "Company") hereby redeems all issued and outstanding Series 2 Class B Shares of the Company as follows:

Cardiogenics Holding – 6295 Northam Drive, Unit 8 Mississauga, Ontario L4V 1W8 T: 905.673.8501 * F: 905.673.9865 (December 22nd, 2010)

Cardiogenics Holding – PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT CardioGenics Holdings Inc. OTCBB: CGNH {Accredited Investors Only} INSTRUCTIONS TO SUBSCRIBER (November 4th, 2010)

The undersigned Investor hereby certifies that the information contained in this Questionnaire is complete and accurate and the undersigned Investor will notify CardioGenics promptly of any change in any such information.

Cardiogenics Holding – Lock-Up Agreement (March 25th, 2010)

THIS LOCK-UP AGREEMENT (this "Agreement") is entered into as of March ___, 2010 by and between __________________________________________ (the "Stockholder") and CARDIOGENICS HOLDINGS INC. a Nevada corporation (the "Company").

Cardiogenics Holding – Lock-Up Agreement (March 16th, 2010)

THIS LOCK-UP AGREEMENT (this "Agreement") is entered into as of March 15, 2010 among Yahia Gawad (the "Gawad"), CARDIOGENICS HOLDINGS INC. a Nevada corporation (the "Company"), CardioGenics ExchangeCo Inc., an Ontario corporation ("ExchangeCo") and WeirFoulds LLP, as "trustee", under the "Trust Agreement described below.

Cardiogenics Holding – Contract (February 16th, 2010)

Cardiogenics Holding – Executive Employment Agreement (February 16th, 2010)

The Executive agrees that upon any termination of his employment with the Corporation he shall immediately tender his resignation from any position he may hold as an officer or director of the Corporation or any of its Affiliates. In the event of the Executive failing within three days to comply with his obligation hereunder, he hereby irrevocably authorizes and appoints each other director and officer of the Corporation as his agent and attorney to sign in his name and on his behalf any written resignations or other documents and do all other things necessary to give effect to such resignation.

Cardiogenics Holding – Llc Membership Interest Purchase Agreement Between Cardiogenics Holdings Inc. As Seller and Rothcove Partners Llc as Buyer (February 16th, 2010)

This LLC Membership Interest Purchase Agreement ("Agreement") is entered into on February 10, 2010, between CARDIOGENICS HOLDINGS INC., a Nevada corporation with a principal place of business at 6295 Northam Drive, Unit 8, Mississauga, Ontario L4V 1W8 ("Seller") and ROTHCOVE PARTNERS LLC, a Nevada limited liability company with a principal place of business at 45 Roth Cove, Hamlin, NY 11464 ("Buyer").

Cardiogenics Holding – Retainer Agreement (February 16th, 2010)

Client shall reimburse WAW for any and all expenses incurred and expenditures made on behalf of the Client during the Term of this engagement. All expenses shall be submitted to the Client with appropriate backup. No mark up will be applied by WAW to any expenses incurred by WAW for the client. These expenses include, but are not limited to, the following: